Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ADRXADARx Pharmaceuticals, Inc.

Nasdaq · CIK 0001802369
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts141

Identity from submissions API

NameADARx Pharmaceuticals, Inc.
CIK0001802369
TickersADRX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN844145188
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone858-283-9472
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO
CA
92121
CA
Mailing address
5871 OBERLIN DRIVE, SUITE 200
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

51 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001729510-26-000012 005-95946 261560982 34 26455
2026-11-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001729510-26-000009 005-95946 261552654 34 9542
2026-11-12 10-Q 10-Q 0001193125-26-458444 001-43482 261547179 34 12706288 1 1
2026-11-12 8-K 8-K 2.02,7.01,9.01 0001193125-26-458321 001-43482 261546834 34 17463259 1 1
2026-10-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001764435-26-000003 005-95946 261466287 34 22359
2026-10-05 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001072613-26-000820 005-95946 261441701 34 179249
2026-10-02 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0000947871-26-000917 005-95946 261438078 34 42199
2026-10-01 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-410626 005-95946 261431202 34 8205
2026-09-30 4 xslF345X06/ownership.xml 0000947871-26-000912 22989
2026-09-30 4 xslF345X06/ownership.xml 0000947871-26-000911 44075
2026-09-30 4 xslF345X06/ownership.xml 0000947871-26-000910 51666
2026-09-29 4 4 0001193125-26-408064 33426
2026-09-29 4 4 0001193125-26-408061 32944
2026-09-29 4 xslF345X06/form4-09302026_010959.xml 0001231919-26-001406 31963
2026-09-28 S-8 S-8 0001193125-26-405447 333-299175 261417976 33 249615 1 1
2026-09-28 4 xslF345X06/form4-09282026_040907.xml 0002153958-26-000004 5722
2026-09-28 4 xslF345X06/form4-09282026_040905.xml 0002154450-26-000004 5734
2026-09-28 4 xslF345X06/form4-09282026_040903.xml 0002151480-26-000004 5701
2026-09-28 4 xslF345X06/form4-09282026_040901.xml 0001729510-26-000006 5675
2026-09-28 4 xslF345X06/form4-09282026_040909.xml 0002153534-26-000004 5731
2026-09-28 8-K 8-K 3.02,5.03,8.01,9.01 0001193125-26-405297 001-43482 261417172 34 193386 1 1
2026-09-28 424B4 424B4 0001193125-26-403094 333-298782 261411636 33 8511842
2026-09-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003052 333-298782 261406085 33 1738
2026-09-24 3 3 0001193125-26-401301 161287
2026-09-24 3 3 0001193125-26-401300 161641
2026-09-24 3 xslF345X06/ownership.xml 0000947871-26-000882 21133
2026-09-24 3 xslF345X06/form3-09242026_100906.xml 0001231919-26-001226 16793
2026-09-24 3 xslF345X06/form3-09242026_100932.xml 0001967360-26-000011 10297
2026-09-24 3 xslF345X06/form3-09242026_100905.xml 0001323304-26-000004 11798
2026-09-24 3 xslF345X06/form3-09242026_100928.xml 0002153534-26-000002 10521
2026-09-24 3 xslF345X06/form3-09242026_100931.xml 0001706399-26-000002 15411
2026-09-24 3 xslF345X06/form3-09242026_100929.xml 0002153958-26-000002 22049
2026-09-24 3 xslF345X06/form3-09242026_100936.xml 0002154450-26-000002 14894
2026-09-24 3 xslF345X06/form3-09242026_100938.xml 0002151480-26-000002 10479
2026-09-24 3 xslF345X06/form3-09242026_100945.xml 0001282930-26-000014 20989
2026-09-24 3 xslF345X06/form3-09242026_100933.xml 0001729510-26-000004 33666
2026-09-24 S-1MEF S-1MEF 0001193125-26-401133 333-299119 261405255 33 187144 1 1
2026-09-24 CERT ADRX_8A_Cert_1802369.pdf 0001354457-26-000906 001-43482 261404255 34 181051
2026-09-22 8-A12B 8-A12B 0001193125-26-397868 001-43482 261396844 34 14492
2026-09-21 S-1/A S-1/A 0001193125-26-396007 333-298782 261392206 33 9495483 1 1
2026-09-14 S-1/A S-1/A 0001193125-26-390724 333-298782 261378124 33 8721648
2026-09-04 S-1 S-1 0001193125-26-383838 333-298782 261362879 33 9991720 1 1
2026-07-31 DRS/A filename1.htm 0001193125-26-328843 377-09495 261229461 33 9143071
2026-06-22 DRS filename1.htm 0001193125-26-277710 377-09495 261108116 33 11337641
2023-08-10 D xslFormDX01/primary_doc.xml 06b 0001802369-23-000002 021-489353 231158541 33 13554
2023-01-26 D xslFormDX01/primary_doc.xml 06b 0001802369-23-000001 021-471878 23557373 33 11995
2021-08-17 D xslFormDX01/primary_doc.xml 06b 0001802369-21-000004 021-410307 211182681 33 11726
2021-05-24 D xslFormDX01/primary_doc.xml 06b 0001802369-21-000003 021-400299 21950637 33 10032
2020-11-17 D xslFormDX01/primary_doc.xml 06b 0001802369-20-000004 021-380734 201319070 33 10074
2020-08-07 D xslFormDX01/primary_doc.xml 06b 0001802369-20-000002 021-372735 201083561 33 9315
2020-02-06 D xslFormDX01/primary_doc.xml 06b 0001802369-20-000001 021-359900 20580574 33 6830

Latest XBRL company facts

One latest value per concept from companyfacts (141 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 111.19M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
ffd NetFeeAmt NetFeeAmt USD 58,236.72 2026-09-28 S-8 2026-09-28 0001193125-26-405447
ffd TtlFeeAmt TtlFeeAmt USD 58,236.72 2026-09-28 S-8 2026-09-28 0001193125-26-405447
ffd TtlOfferingAmt TtlOfferingAmt USD 421.70M 2026-09-28 S-8 2026-09-28 0001193125-26-405447
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-28 S-8 2026-09-28 0001193125-26-405447
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-24 S-1MEF 2026-09-24 0001193125-26-401133
us-gaap AccountsAndFinancingReceivableAllowanceForCreditLoss Accounts and Financing Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 396,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 11.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 4.27M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 4.44M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -2.15M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 873.78M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions APIC, Share-based Payment Arrangement, Recognition and Exercise USD 134,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.93M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 4,271 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 13.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap Assets Assets USD 929.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AssetsCurrent Assets, Current USD 918.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 893.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 332.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 330.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 26,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 570.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 570.61M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 504.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 22.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1000.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 107.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 107.26M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap CommonStockValue Common Stock, Value, Issued USD 11,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -80.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 330.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DeferredIncomeNoncurrent Deferred Income, Noncurrent USD 305.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 20.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.02 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap Depreciation Depreciation USD 920,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -6.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -6.46 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 135,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 66,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -5.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 4.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 11.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap InterestIncomeOperating Interest Income, Operating USD 11.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LeaseCost Lease, Cost USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 556,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.27M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 901,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap Liabilities Liabilities USD 354.66M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 929.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap LiabilitiesCurrent Liabilities, Current USD 43.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 502.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 78.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -76.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -76.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 12.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingExpenses Operating Expenses USD 94.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -89.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.082 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 100,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 32,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -1.37M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -4.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 815,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 1.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 2.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 51.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 641,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 415.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 494.90M 2026-09-28 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 131.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 474,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 8.84M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 4.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 75.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -297.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 5.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 19.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 4.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.921 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.046 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 128.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 7.13M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 1.92 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 2.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 6.18 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 10.36 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 188.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 13.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.82 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.08 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 10.79 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShortTermInvestments Short-term Investments USD 330.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 574.40M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 442,366 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 357.62M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 407.38M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 450,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap VariableLeaseCost Variable Lease, Cost USD 737,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 11.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 11.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458444

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →